TCM Pharma ApS: Financial statements 2021
CVR: 39022508
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
TCM Pharma ApS (CVR 39022508) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 458,269 and a net result of DKK 133,616 compared with DKK -275,872 the year before. That is an increase of 587.2% compared with the year before. Equity in the 2021 report amounted to DKK -214,488.
- Gross Profit
- DKK 458,269
- Profit/Loss
- DKK 133,616
- Equity
- DKK -214,488
- Total Assets
- DKK 1,284,795
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 458 t. | 134 t. | -214 t. | - |
| 2020 | - | 67 t. | -276 t. | -348 t. | 0 |
| 2019 | - | -17 t. | -114 t. | -72 t. | - |
Official annual report
Find more companies like TCM Pharma ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
TCM Pharma ApS has published its annual report for 2020. Gross profit came to DKK 66,690, and the net result was DKK -275,872.
About TCM Pharma ApS
TCM Pharma ApS is a Danish company of the type Anpartsselskab based in Farsø, founded in 2017. The company is under bankruptcy. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Løgstørvej 80 ApS and S. Greenhouse ApS. The company is owned by A.T.L. Holding ApS. The company has 1 employee (2022). In 2023, the company reported a gross profit of DKK 223,313 and a net result of DKK 136,379 compared with DKK -163,358 the year before. Equity in the 2023 report amounted to DKK 53,353.